Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 3
2000 2
2001 3
2002 2
2005 2
2006 2
2007 3
2008 4
2009 3
2010 3
2011 3
2012 4
2013 4
2014 4
2015 4
2016 8
2017 5
2018 3
2019 5
2020 9
2021 7
2022 6
2023 4
2024 10
2025 12
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Nirsevimab Immunization to Prevent Pediatric RSV Hospitalizations.
Attaianese F, Carreras G, Trapani S, Alberti I, Aricò M, Attanasi M, Bertolucci G, Bressan S, Caselli D, Casotto V, Cazzato S, Chiarelli F, Felici E, Frusciante A, Galeone MA, Garazzino S, Giannattasio A, Gitto E, Guerriero A, Guida F, Iudica G, Lanari M, Mandato C, Manzini A, Martelli G, Milani GP, Moriondo M, Notarangelo LD, Nunziata F, Pellegrino R, Peroni D, Piccotti E, Ponticiello E, Ricci S, Rulli I, Savoia F, Silvestro E, Sisto A, Soro F, Tonetto S, Zago A, Dani C, Azzari C, Indolfi G. Attaianese F, et al. Among authors: moriondo m. JAMA Pediatr. 2026 Jul 1;180(7):783-791. doi: 10.1001/jamapediatrics.2026.0657. JAMA Pediatr. 2026. PMID: 41973439 Free PMC article.
Effectiveness of a targeted infant RSV immunization strategy (2024-2025): A multicenter matched case-control study in a high-surveillance setting.
Attaianese F, Trapani S, Agostiniani R, Ambrosino N, Bertolucci G, Biasci P, Castelli B, Colarusso G, Coretti G, Dani C, Grosso S, Lucenteforte E, Maj D, Martini M, Mirri G, Moriondo M, Perone V, Peroni D, Rossetti A, Ricci S, Sarli WM, Simone V, Sollai S, Tonnarini C, Varone M, Vasarri P, Azzari C, Indolfi G. Attaianese F, et al. Among authors: moriondo m. J Infect. 2025 Sep;91(3):106600. doi: 10.1016/j.jinf.2025.106600. Epub 2025 Aug 21. J Infect. 2025. PMID: 40848988 Free article.
Public health impact of nirsevimab and reduction of RSV hospitalisation in all infants: early real-world data from Tuscany (Italy) in the 2024-25 RSV season.
Nieddu F, Vignoli M, Ferraro E, Boscia S, Astorino V, Pelosi C, Guarnieri V, Quaranta F, Perone V, Biasci P, Lodi L, Ricci S, Dani C, Indolfi G, Bourron P, Parisi S, Azzari C, Moriondo M. Nieddu F, et al. Among authors: moriondo m. Eur J Pediatr. 2025 Nov 3;184(11):728. doi: 10.1007/s00431-025-06588-6. Eur J Pediatr. 2025. PMID: 41182397 Free PMC article.
The impact of nirsevimab prophylaxis on RSV hospitalizations: a real-world cost-benefit analysis in Tuscany, Italy.
Lastrucci V, Pacifici M, Alderotti G, Puglia M, Berti E, Barbati F, Lodi L, Boscia S, Nieddu F, Indolfi G, Peroni D, Martini M, Azzari C, Voller F, Moriondo M, Ricci S. Lastrucci V, et al. Among authors: moriondo m. Front Public Health. 2025 Jul 3;13:1604331. doi: 10.3389/fpubh.2025.1604331. eCollection 2025. Front Public Health. 2025. PMID: 40678647 Free PMC article.
Severe Presentations and Outcomes in Hospitalized Pediatric Patients With Parvovirus B19 Infection During the 2024 Outbreak: A Multicenter Prospective Study in Italy.
Venturini E, Tamborino AM, Arrichiello G, Attaianese F, Calò Carducci FI, Cafagno C, Caselli D, De Luca M, Garbo V, Giacomet V, Liberati C, Lancella L, Licari A, Maglione M, Midulla F, Moracas C, Moriondo M, Poeta M, Rossini C, Guarino A, Galli L. Venturini E, et al. Among authors: moriondo m. Pediatr Infect Dis J. 2026 Feb 1;45(2):e37-e42. doi: 10.1097/INF.0000000000005014. Epub 2025 Oct 15. Pediatr Infect Dis J. 2026. PMID: 41090940
Serotype 3 invasive pneumococcal disease in Tuscany across the eras of conjugate vaccines (2005-2024) and anthropic-driven respiratory virus fluctuations.
Lodi L, Catamerò F, Sarli WM, Moriondo M, Nieddu F, Ferraro E, Citera F, Astorino V, Giovannini M, Voarino M, Pelosi C, Quaranta F, Lippi F, Canessa C, Ricci S, Azzari C. Lodi L, et al. Among authors: moriondo m. Hum Vaccin Immunother. 2025 Dec;21(1):2510005. doi: 10.1080/21645515.2025.2510005. Epub 2025 Jun 17. Hum Vaccin Immunother. 2025. PMID: 40526905 Free PMC article.
Clinical Features and Predictors of Severity in Children Hospitalized With Human Metapneumovirus: A Multicenter Italian Study.
Sgubbi S, Corso CM, Poeta M, Abrate G, Albano C, Anania C, Cafagno C, Colomba C, De Luca M, Denina M, Folgori L, Galli L, Garbo V, Giacomet V, L'Assainato S, Maglione M, Midulla F, Moracas C, Moriondo M, Petrarca L, Piralla A, Valentino MS, Venturini E, Guarino A, Licari A. Sgubbi S, et al. Among authors: moriondo m. Pediatr Infect Dis J. 2026 Jun 2. doi: 10.1097/INF.0000000000005295. Online ahead of print. Pediatr Infect Dis J. 2026. PMID: 42226059 Free article.
116 results